Table 1.
Incidence of diabetes in CD-1 mice treated with ERW and alloxan
Weeks after ALX administration | 6th week | 7th week | 9th week | 9th week | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Blood sugar level (mg/dL) | 150–350 | >350 | Death | 150–350 | >350 | Death | 150–350 | >350 | Death | >150 |
Control (n = 12) | 2 | 4 | 1 | 5 | 5 | 2 | 2 | 7 | 3 | 100% |
ERW (n = 12) | 5 | 0 | 0 | 4 | 2 | 0 | 3 | 4 | 0 | 58.3% |
Male ICR(CD-1 strain) mice were administrated ultrapure water (control) and ERW. At the 4th week time point, ALX was injected intraperitoneally 3 times and number of mice exhibiting abnormal blood sugar levels and dead mice were determined. Mice with basal glucose levels under the fasting condition ranging between 150 and 350 mg/dL were considered mild ALX-induced diabetic mice, and higher than 350 mg/dL were as severe ALX-induced diabetic mice. At 9th week, the incidence rate of mice exhibiting blood sugar levels more than 150 mg/dL were also shown